Acurx Announces Scientific Partnership with Leiden University Medical Center to Advance Development of Acurx's DNA Polymerase IIIC Inhibitor Antibiotics

Summary

Acurx announced a scientific partnership with Leiden University Medical Center to advance development of its DNA polymerase IIIC inhibitor antibiotics, building on prior research funded by Health-Holland that demonstrated positive results with ibezapolstat.